The New York Times - Business:
A worrisome scarcity of cancer drugs has heightened concerns about the troubled generic drug industry. Congress and the White House are seeking ways to address widespread supply problems.
Author: Christina Jewett
This post first appeared in The New York Times - Business. Read the original article.
